The molecular interaction between smooth muscle (SM) myosin and actin in the corpus cavernosum (CC) determines the erectile state of the penis. A key mechanism regulating this interaction and subsequent development and maintenance of force is alternative splicing of SM myosin heavy chain (MHC) and 17 kDa essential SM myosin light chain (MLC) pre-mRNAs. Our aim was to examine the relative SM myosin isoform composition in human CC. Tissue samples were obtained from 18 patients with erectile dysfunction (ED), Peyronie's disease, or both. One specimen was obtained during a transgender operation. Patients then were stratified according to presence of diabetes mellitus, hypertension, ED, or Peyronie's disease, as well as failure of phosphodiesterase-5 (PDE5) inhibitors and history of previous pelvic or penile surgeries, radiation, or both. Our results revealed that all human CC samples expressed only the SM-A isoform. There was a predominance of SM2 isoform mRNA relative to SM1 across all samples, with a mean of 63.8%, which correlated with protein analysis by gel electrophoresis. A statistically significant difference was found between patients who had undergone previous pelvic surgery, radiation, or both and those who did not. The ratio of LC 17b to LC 17a was approximately 1:1 for all patients, with a mean of 48.9% LC 17b . Statistical difference was seen in the relative ratio of LC 17b to LC 17a among the group who failed conservative therapy with PDE5 inhibitors compared with all others. In conclusion, we determined the SM myosin isoform composition of human CC and present for the first time differences in relative myosin isoform expression among patients with several risk factors contributing to their cause of ED. Our data reflect the fact that alternative splicing events in the MHC and 17 kDa MLC pre-mRNA may be a possible molecular mechanism involved in the altered contractility of the CCSM in patients with ED.
Introduction
Erectile dysfunction (ED) is a condition that affects a substantial number of men. As of 1995, it was estimated that more than 152 million men worldwide experienced ED. 1 Moreover, it is projected that by 2025, this number will more than double, mostly because of the aging population. 1 Other common predisposing risk factors for ED include diabetes, hypertension, coronary artery disease, peripheral vascular disease, smoking, prior pelvic surgery, Peyronie's disease, and more recently, the presence of lower urinary tract symptoms (LUTS). [2] [3] [4] The state of penile tumescence and detumescence is a highly regulated process involving the relaxation and contraction, respectively, of the smooth muscle (SM) within the two corpora cavernosa (CC) of the penis. Failure or a defect of this important interaction results in the inability to obtain or maintain an erection. Much emphasis has been placed on the CC SM (CCSM) relaxation mechanisms as the crucial step in penile tumescence, such as the nitric oxide/cGMP-dependent pathway that has been so highly publicized with the advent of the phosphodiesterase-5 (PDE5) inhibitors. However, much less attention has been placed on the contraction mechanism for penile erection, including the foundation of the contractile mechanism in penile SM, that being the actin-myosin apparatus.
SM myosin is composed of a pair of myosin heavy chains (MHC) and two pairs of myosin light chains (MLC 17 and MLC 20 ) that are intimately intertwined. 5 Although phosphorylation of the MLC 20 has been shown to correlate directly with force production, 6 the SM myosin isoform composition also has been demonstrated to affect force development 7 as well as force maintenance. 8 In vertebrates, the mRNAs that encode SM MHC (SMMHC) exist as several different isoforms that are produced from a single SMMHC gene through alternative splicing mechanisms at both the 5 0 and 3 0 end of the coding region. 9, 10 It has been shown that the amino terminal isoform from MHC mRNA of uterus and aortic SM (known as SM-A) is different from the major SMMHC isoform found in intestinal and urinary bladder SM (known as SM-B) because of alternative splicing at the 5 0 end coding region.
11,12
The SM-B isoform has an additional 21-nucleotide insertion that encodes seven amino acids at the N-terminal region, which is next to the adenosine triphosphate (ATP)-binding site in the globular head of the myosin molecule and is correlated with actinactivated Mg 2 þ -ATPase activity, velocity of movement of actin filaments in vitro, and maximum shortening velocities that are higher than those in SM that have predominantly the SM-A isoform. 12, 13 Thus, the SM-B isoform is predominantly found in SM that demonstrate a more phasic contractile nature (e.g., urinary bladder), whereas the SM-A isoform is found in more tonic type SM (e.g., aorta). 14 The C-terminal isoforms (SM1 and SM2) are similarly generated by alternative splicing, but at the 3 0 end of the MHC mRNA. 10 SM1 has been shown to form superior contractile filaments compared with SM2 in vitro, 15 yet both demonstrate similar in vitro ATPase activities 16 and maximal shortening velocities. 17 Differing ratios of SM2-to-SM1 have been correlated with various organ types with higher ratios found in phasic tissue such as urinary bladder 18 and more equal ratios in tonic SM such as aorta. 12 MLC isoforms also exist subsequent to pre-mRNA alternative splicing mechanisms as well. 19, 20 Such an occurrence at the 3 0 end of the MLC 17 mRNA produces the essential MLC isoforms LC 17a and LC 17b . The LC 17a isoform is the major MLC isoform found in more phasic SMs such as urinary bladder, 14 which tends to generate more force, whereas LC 17b is coexpressed with LC 17a in a more equal ratio within more tonic-type SM 12, 14 and is correlated with slower shortening velocities. 21 The alternative splicing of the known SM myosin isoforms examined in this study along with their known effects on SM contractility are summarized in Table 1 .
Alterations in SM myosin isoform composition have now been documented in a number of pathological conditions, including bladder outlet obstruction, 14 megacolon, 22 and pulmonary hypertension. 23 In addition, a direct role for SM myosin isoform composition in altering physiological properties of SM has been demonstrated using SM-B knockout mice. 7 DiSanto et al. 24 characterized the ratio of SM2-to-SM1 MHC within rabbit CCSM and determined it to be 1. RNA extraction and reverse transcriptase polymerase chain reaction Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Briefly, the tissue was ground into a powder using a mortar and pestle cooled in liquid nitrogen, without allowing the 
In addition, known effects of increased expression of these isoforms relative to their alternatively spliced counterpart (SM-A/ SM-B, SM1/SM2 and LC 17a /LC 17b ) are listed. A dash indicates no conclusive effect shown to date.
Human corpus cavernosum myosin isoform expression PT Koi et al tissue to thaw. The powder then was homogenized immediately in denaturing buffer using a T8 UltraTurrax minielectric homogenizer (IKA Works, Wilmington, NC, USA), chloroform was added and mixed, the phases separated by centrifugation, and the RNA precipitated by isopropanol and then washed with 70% ethanol and dissolved in RNasefree sterile water. The resulting RNA was quantitated by spectrophotometry at 260/280 nm. Total RNA (1 mg) then was reverse transcribed using 0.5 mg oligo (dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen), 500 mM dNTPs (Invitrogen), and 200 U of SuperScript II RNase H reverse transcriptase in a total volume of 20 ml for 60 min at 421C. Polymerase chain reaction (PCR) was performed on 2 ml of the reverse transcribed cDNA using 2 units of Red Taq 
(231/ 275). The primers were designed based on human Genbank sequences (SM-B (AY520817), SM2 (accession # AF013570), LC17 b (accession # HS02629)) and synthesized by Invitrogen. The PCR was performed using a GeneAmp 9700 thermal cycler (Applied Biosystems, Foster City, CA, USA). The cycling conditions were an initial 5 min at 941C followed by 35 cycles (30 s at 941C, 30 s at 551C, and 120 s at 721C), followed by a final one-time 7 min incubation at 721C to ensure extension of all products. The PCR products were separated by electrophoresis on a 2% agarose gel and were visualized using ethidium bromide staining and ultraviolet illumination. Band density was quantified by reflectance scanning of gel photographs obtained with a BioDoc-It camera setup (UVP, Upland, CA, USA) using a Bio-Rad (Hercules, CA, USA) GS-700 imaging densitometer and subsequent analyses using the Bio-Rad Molecular Analyst 1D program. Standard curves were constructed for all primer sets to ensure that amplifications, photo capture, and scanning were in the linear range. By generating primer pairs designed specifically to flank the insertion regions of SM-A/SM-B, SM1/SM2 and LC 17a /LC 17b we allowed for competitive PCR amplification that enabled us to obtain quantitative relative myosin isoform expression data for all isoform pairs.
Protein extraction and separation of SM1 and SM2 Corporal tissue was ground in liquid nitrogencooled mortars as in the method described above for RNA extraction. Total protein extracts were prepared and protein concentration was determined using the BioRad DC protein determination kit, both as previously described. 25 Next, the SM1 and SM2 isoforms were separated also as previously described. 24, 25 Briefly, 80 mg total protein extract was electrophoresed on a slowly running large format (16 Â 16 cm) 4.5% highly porous SDS-PAGE gel overnight using a Bio-Rad Protean II xi electrophoresis unit. The protein bands then were stained with Coomassie blue, and band intensities were scanned and analyzed using a densitometer as described above.
Statistical analysis
Values are expressed as mean7s.e. A parametric two-tailed unpaired t-test was performed using a commercially available computer program (GraphPad Software, San Diego, CA, USA) to assess significance of differences of relative isoform expression. A P-value o0.05 was considered to be statistically significant.
Results

Patient demographics
Tissue from a total of 19 patients was analyzed. The mean age of the patients studied was 60.3 years, with a range of 33-79 years. Seventeen patients were more than 50 years of age. Two were 33 and 45 years of age. The patient characteristics were as follows with overlap: 14 had ED, eight had diabetes, 10 had hypertension, six had Peyronie's disease and seven had prior pelvic surgery, radiation, or both. Eight of the patients with ED were refractory to PDE5 inhibition.
MHC isoform expression SM-A/SM-B.
The CC from all patients exhibited nearly 100% expression of the SM-A isoform (Figure 1 ). Although some of the CC samples obtained from patients without documented ED did express detectable levels of the SM-B isoform, relative expression did not reach more than a 5% level (Figure 1, lane 1) . For comparison, control cDNA that has nearly equal amounts of the SM-A and SM-B isoforms was amplified and is shown for comparison ( Figure 1, lane 6) . SM1/SM2. The mean relative percentage of the SM2 isoform was 63.8%, which equates to an SM2-to-SM1 ratio of approximately 1.7:1 ( Figure 2) . The only three patients in whom o60% of the SM2 mRNA was expressed were nondiabetic, but the difference between relative SM2 expression in CC from diabetic and nondiabetic patients did not reach statistical significance (Figure 3a) . However, seven patients demonstrated more than 65% of the SM2
Human corpus cavernosum myosin isoform expression PT Koi et al isoform. On stratification, six of the seven patients (86%) had a history of radical prostatectomy, prostate brachytherapy, external beam radiation or penile revascularization (see Figure 2 , lanes 3 and 4). Statistical significance was seen within this group of patients compared with others who did not have the described procedures (Figure 3f) . At the mRNA level, there was no significant difference between the SM1/SM2 composition in men with ED versus men with no ED (Figure 3c ) or other stratifications (Figures 3b, d , and e).
Expression of MHC isoforms at the protein level.
Unlike the approximate 0.8-kDa difference between the SM-A and SM-B isoforms, the SM1 and SM2 isoforms differ by approximately 4 kDa and under exacting conditions can be separated by SDS-PAGE (see Materials and methods). Thus, we determined whether the expression patterns of SM1/SM2 at the mRNA level were correlated with protein level expression by resolving total CC protein extracts on highly porous 4.5% SDS-PAGE gels ( Figure 4) . As a result of the limited amounts of tissue, CCs from only five of the 19 patients were analyzed. The demographics of these five patients were as follows, with overlap: three were diabetic, two failed to respond to PDE5 inhibitors, two had normal erectile function, one had undergone previous pelvic surgery or radiation, one had undergone a transgender operation after initiation of hormone therapy, and one had Peyronie's disease. The ratio of SM2 to SM1 on the separating gel correlated with the mRNA levels obtained by RT-PCR in that all the CC samples expressed predominantly SM2 with an average SM2:SM1 ratio of 1.34 (57.3% SM2). Of note, the two highest ratios of 1.6:1 and 1.4:1 belonged to the two patients who did not have ED (Figure 4 , lanes 1 and 5), whereas the three samples from patients with ED exhibited lower ratios of 1.2:1, 1.2:1 and 1.3:1 ( Figure 4, lanes 2-4) . 
Discussion
We have characterized the relative expression of SM myosin isoforms in human CC obtained from 19 different men during surgery. One of the most striking findings of our study was that all of the human CC samples obtained from men with ED expressed nearly 100% of the lower ATPase SM-A isoform and undetectable levels of the alternatively spliced higher ATPase SM-B isoform. This finding is in marked contrast to CC obtained from normal rabbits, in which we previously reported a consistent expression of approximately 31% SM-B relative to SM-A myosin 24 and from normal rat CC, which has been recently identified as having a 450% expression of the SM-B SMMHC isoform expression relative to SM-A (unpublished data).
As the SM-A isoform is the predominant 5 0 MHC isoform found in SMs that exhibit a more tonic-type contraction, 14, 26 our study (although limited to 19 men) suggests that relative overexpression of SM-A in men with ED may be associated with a more tonically contracted CCSM. Indeed, SM-B knockout mice exhibit decreased SM shortening velocities 7 that are consistent with more cross-bridges being attached, 27 and thus an increase in the maintenance Human corpus cavernosum myosin isoform expression PT Koi et al of force. The resulting higher CCSM tone could make endogenous CCSM relaxation mechanisms less effective. Relative expression of the LC 17b MLC isoform is highest in more tonic-type muscles such as in the aorta, where there is approximately 50% expression of LC 17b . 21 Several studies have shown that LC 17b seems to attenuate contraction. 28, 29 In addition, it is known that the increased relative expression of LC 17b correlates positively with the relative expres- 
Human corpus cavernosum myosin isoform expression
PT Koi et al sion of SM-A. 14, 30 We found a nearly 50% expression of LC 17b relative to LC 17a across all of the human CC samples with ED, which correlates with our very high relative expression of SM-A. This 50% relative expression level of LC 17b (similar to what is found in the aorta) in the CC of men with ED is much higher than the only 13% expression that was previously reported for the normal rabbit CCSM 24 and again suggests a more tonically contracted CCSM that may be more resistant to endogenous SM relaxation mechanisms and could be involved in the mechanism for organic-based ED. Relative expression of LC 17b is also much higher in the tonic-type esophageal sphincter compared with the more phasic-type esophageal body, 26 again suggesting a role for the LC 17b essential MLC isoform in determining the tonicity of SM contraction.
Stratification of our samples based on ED or Peyronie's disease revealed no significant differences between the samples with regard to LC 17a / LC 17b isoform composition. Further stratification based on diabetes mellitus, hypertension, resistance to PDE5 inhibitors, and history of previous pelvic surgery or radiation revealed significant differences only for patients who were refractory to PDE5 inhibitors. This group of patients demonstrated a significantly lower relative expression of LC 17b compared with all others. At present, the relationship between this decreased LC 17b relative expression and resistance to PDE5 inhibitors remains unknown. One possible explanation is that prior exposure of these patients to PDE5 inhibitors, although not sufficient to correct their ED, may have had some positive effects that included a decrease in LC 17b relative expression. Owing to the limited amount of human CC tissue, we were not able to examine LC 17a /LC 17b relative protein expression that would require 2-dimensional electrophoresis but plan to do so in future studies. However, our prior studies have shown a good correlation between LC 17a /LC 17b relative expression at the mRNA and protein levels. 14, 24 Finally, concerning SM myosin isoform expression, we also examined the expression of the SM1/ SM2 alternatively spliced SMMHC isoforms. Our results showed that there was on average 63.8% mRNA and 57.3% protein level expression of SM2 relative to SM1 across all of the human CC samples examined. The protein expression level is similar to the 52.3% relative protein expression level of SM2 that was previously reported for the normal rabbit CC. 24 On stratification for risk factors, there were no significant differences among the various subgroups with the exception of CC samples from men who had undergone previous pelvic surgery or radiation. This group of men exhibited a significantly higher relative expression of SM2 compared with all others. Although the mechanistic basis for the increased relative SM2 expression in this subpopulation remains unknown, a recent study by Damon 31 showed that the degree of sympathetic innervation was associated with the state of vascular SM differentiation. Based on this observation, one could hypothesize that relative expression of SM2 may have been independently modulated by damage to neural tissue occurring in this subpopulation that underwent prior pelvic surgery or radiation.
Conclusions
We report, for the first time, the characterization of SM myosin isoforms within the human CC. For a human study, the 19 clinically well-characterized CC specimens analyzed in the current study represents a fairly large sample population. Our most striking finding was that none of the CC samples obtained from men with clinically diagnosed ED expressed an appreciable amount of mRNA for the high ATPase SMMHC isoform SM-B, but rather expressed only the lower ATPase SM-A isoform. Correlating with the very high relative expression of SM-A, we found a high relative expression of the LC 17b MLC isoform. The relative overexpression of these two isoforms, both of which are associated with a tonic-type SM phenotype, are in marked contrast to previously reported expression of these isoforms in normal rabbit CC and would be expected to result in a heightened CCSM tone that would be more resistant to endogenous SM relaxation pathways and might be at least partly involved in the mechanism for ED.
In addition to the limited sample size, an obvious limitation of this type of human study is that it is generally not possible to obtain completely normal human CC tissue. Indeed the non-ED samples in the current study were obtained from men either with Peyronie's disease or that underwent hormonal therapy before a transgender operation. Therefore, the fact that our CC samples from patients without ED did not exhibit SM-B levels equivalent to the normal rabbit is not conclusive. To check that the approximately 30% expression of SM-B in the normal rabbit was not a species-specific peculiarity, we also examined the expression of SM-B in the rat CC. Interestingly, the normal rat CC expressed relative amounts of the SM-B isoform at levels even higher than normal rabbit, again suggesting a pathological alteration in the CC of the men with ED. In summary, our data reflect the fact that alternative splicing events in the MHC and 17 kDa MLC pre-mRNA may be a possible molecular mechanism involved in the altered contractility of the CCSM in patients with ED.
